The
American Bar Association (ABA) Center for Continuing Legal Education and ABA
Section of Science & Technology Law will be offering a teleconference and
live audio webcast entitled "Navigating the U.S. Biosimilar Pathway"
on June 29, 2010 from 1:00 - 2:30 PM (EST). Dr. William Simmons of Sughrue Mion, PLLC; Kenneth Burchfiel
of Sughrue Mion, PLLC; Krista Hessler Carver of Covington & Burling LLP;
and Michael Dzwonczyk of Sughrue Mion, PLLC will explore the new U.S.
biosimilars pathway, including risks confronting biosimilar producers.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Regents of the University of California v. Broad Institute, Inc. (Fed. Cir. 2025)
- PocketPair Provides Post on Permutations to Palworld based on Pokémon Patents
- Regents of the University of California v. Broad Institute (Fed. Cir. 2025)
- Valve Corp. v. Ironburg Inventions Ltd. (Fed. Cir. 2025)
- U.S. Trade Representative Releases 2025 Special 301 Report
- Metacel Pharmaceuticals LLC v. Rubicon Research Private Ltd. (Fed. Cir. 2025)
- Recentive Analytics, Inc. v. Fox Corp. (Fed. Cir. 2025)
- Sage Products, LLC v. Stewart (Fed. Cir. 2025)
- Recor Medical, Inc. v. Medtronic Ireland Mfg. (Fed. Cir. 2025)
- Newman v. Moore -- Down to a "Battle of the Experts"?
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« Webcast on Opportunities and Challenges Facing Life Science Companies | Main | Patent Reform Seminar »
May 28, 2010
The comments to this entry are closed.
May 2025
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (278)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (107)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (27)
- District Court (223)
- Double Patenting (42)
- Enablement (53)
- Federal Circuit (1042)
- Food and Drug Administration (112)
- Hatch-Waxman (96)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (29)
- Infringement - Literal or DOE (93)
- Injunction (39)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (169)
- News from Abroad (102)
- Novelty (76)
- Obviousness (239)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (218)
- Patent Office Rules & Procedures (833)
- Patent Profiles (104)
- Patent Prosecution (100)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (373)
- Patentable Subject Matter (646)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (8)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (90)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments